Our researchers work across the full range of biomedical and clinical sciences, from the molecule to large population studies. The excellence of our research is recognised by our top placing in international league tables and top ranking for overall quality in the Research Excellence Framework.
30 July 2020
Infectious disease and clinical machine learning experts at the University of Oxford have developed an Artificial Intelligence test that can rapidly screen for COVID-19 in patients arriving in emergency departments, and a preprint paper has been published on its effectiveness.
30 July 2020
An in-depth look into a collaborative Department of Physiology, Antomy and Genetics (DPAG), Chemistry and Oxford Martin School project pioneering a radical new approach in which the brain is repaired with 3D-printed neural tissues.
28 July 2020
Collaborative Cancer Research UK-funded studies from University of Oxford researchers have uncovered a new mechanism by which cancer cells adapt to the stresses they encounter as they grow and respond to therapies. This mechanism involves cells releasing small vesicles, known as exosomes.
New study enables identification of people at particular risk of rare, but serious, muscle-related side effect of statin therapy
24 July 2020
Statins are prescribed to millions of people worldwide to reduce their risks of suffering heart attacks and strokes. Researchers at the Nuffield Department of Population Health, in collaboration with other researchers, have published new findings that identify a combination of factors that put some patients at higher risk of myopathy, which is a rare side-effect of statin therapy characterised by muscle pain or weakness in combination with high blood levels of creatine kinase, a marker of muscle damage.
Pictures courtesy of: Nasir Hamid, OU Images and Shutterstock